New therapeutic pathway may keep cancer cells turned 'off'

A new study offers tangible evidence that it is possible to keep osteosarcoma lesions dormant using novel nanomedicines. Osteosarcoma is a cancer that develops in the bones of children and adolescents. It is one of the most aggressive cancers, with only a 15 per cent, five-year survival rate when diagnosed in an advanced metastatic stage.